U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07200596) titled 'The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects' on Sept. 23.

Brief Summary: The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single-dose subcutaneous injection of SHR-3045 in healthy subjects.

Study Start Date: Oct., 2025

Study Type: INTERVENTIONAL

Condition: Rheumatoid Arthritis (RA)

Intervention: DRUG: SHR-3045 Injection

SHR-3045 injection.

DRUG: SHR-3045 Placebo Injection

SHR-3045 placebo injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Published by HT...